CS logo
small CS logo
Krakowski Szpital Specjalityczny im. Jana Pawla II, Oddzial Kliniczny Chorob Serca i Naczyn

Krakow, Poland
Hospital in Kraków
Prądnicka 80, 31-215 Kraków

About Krakowski Szpital Specjalityczny im. Jana Pawla II, Oddzial Kliniczny Chorob Serca i Naczyn


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Actelion
5
United Therapeutics
2
Total Rows: 2

Clinical Trials at Krakowski Szpital Specjalityczny im. Jana Pawla II, Oddzial Kliniczny Chorob Serca i Naczyn


During the past decade, Krakowski Szpital Specjalityczny im. Jana Pawla II, Oddzial Kliniczny Chorob Serca i Naczyn conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
2017-07-11
2021-03-12
Completed
143
Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects
2017-08-14
2021-07-26
Completed
142
A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
2018-08-30
2023-12-01
Recruiting
1,000
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
2019-09-23
2024-09-01
Enrolling by invitation
1,000
A Long Term Study to Find Out if Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
2018-12-07
2021-10-12
Terminated
91
An Upcoming Clinical Study to Measure the Safety and Impact of a Drug Called Macitentan in Teenage and Adult Fontan Patients.
2019-04-11
2022-01-18
Terminated
112
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension
2020-06-30
2026-09-21
Recruiting
900

Rows per page:

1–7 of 7

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Krakowski Szpital Specjalityczny im. Jana Pawla II, Oddzial Kliniczny Chorob Serca i Naczyn" #1 collaborator was "Medidata Solutions" with 2 trials as a collaborator, "AcitGraph" with 1 trials as a collaborator, "ActiGraph LLC" with 1 trials as a collaborator, "Almac Clinical Technologies" with 1 trials as a collaborator and "Almac Clinical Technologies, LLC" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Krakowski Szpital Specjalityczny im. Jana Pawla II, Oddzial Kliniczny Chorob Serca i Naczyn


According to Clinical.Site data, the most researched conditions in "Krakowski Szpital Specjalityczny im. Jana Pawla II, Oddzial Kliniczny Chorob Serca i Naczyn" are "Pulmonary Arterial Hypertension" (3 trials), "Cardiovascular Diseases" (2 trials), "Connective Tissue Diseases" (2 trials), "Familial Primary Pulmonary Hypertension" (2 trials) and "Hypertension" (2 trials). Many other conditions were trialed in "Krakowski Szpital Specjalityczny im. Jana Pawla II, Oddzial Kliniczny Chorob Serca i Naczyn" in a lesser frequency.

Clinical Trials Intervention Types at Krakowski Szpital Specjalityczny im. Jana Pawla II, Oddzial Kliniczny Chorob Serca i Naczyn


Most popular intervention types in "Krakowski Szpital Specjalityczny im. Jana Pawla II, Oddzial Kliniczny Chorob Serca i Naczyn" are "Drug" (7 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Macitentan 10 mg" (2 trials), "Ralinepag" (2 trials), "macitentan 10 mg" (2 trials) and "Macitentan" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Krakowski Szpital Specjalityczny im. Jana Pawla II, Oddzial Kliniczny Chorob Serca i Naczyn


The vast majority of trials in "Krakowski Szpital Specjalityczny im. Jana Pawla II, Oddzial Kliniczny Chorob Serca i Naczyn" are 7 trials for "All" genders.

Clinical Trials Status at Krakowski Szpital Specjalityczny im. Jana Pawla II, Oddzial Kliniczny Chorob Serca i Naczyn


Currently, there are NaN active trials in "Krakowski Szpital Specjalityczny im. Jana Pawla II, Oddzial Kliniczny Chorob Serca i Naczyn". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Krakowski Szpital Specjalityczny im. Jana Pawla II, Oddzial Kliniczny Chorob Serca i Naczyn, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Krakowski Szpital Specjalityczny im. Jana Pawla II, Oddzial Kliniczny Chorob Serca i Naczyn, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status